LAGUNA HILLS, Calif., March 19, 2026--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment ...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac ...

Trial assessed outcomes of quitting therapy after 1 year among select MI survivors ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial ...

Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit ...

A 60-second electrocardiogram recorded while a racehorse trots during its warm-up could identify animals at risk of dangerous ...

Memantine has demonstrated efficacy in suppressing premature atrial contractions in a phase II trial. The study showed a reduction in both atrial ectopy and overall atrial tachyarrhythmia ...

Medically reviewed by Elizabeth Barnes, RDN Key Takeaways Melatonin may be a useful sleep aid for some, but it can cause some side effects like headaches, nausea, drowsiness, and dizziness.You may be ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally ...

Scientists created virtual replicas of patients’ diseased hearts so precise that blocking a dangerous irregular heartbeat in ...

Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mavacamten saw a significant ...

The ventricles share a common septum and, therefore, the filling of one influences the compliance of the other. This phenomenon is known as direct diastolic ventricular interaction. The interaction is ...